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OPEN
ORIGINAL ARTICLE
Genome-wide association study identifies novel loci
associated with resistance to bovine tuberculosis
ML Bermingham1, SC Bishop1, JA Woolliams1, R Pong-Wong1, AR Allen2, SH McBride2, JJ Ryder3,4,
DM Wright3,5, RA Skuce2,3, SWJ McDowell2 and EJ Glass1
Tuberculosis (TB) caused by Mycobacterium bovis is a re-emerging disease of livestock that is of major economic importance
worldwide, as well as being a zoonotic risk. There is significant heritability for host resistance to bovine TB (bTB) in dairy
cattle. To identify resistance loci for bTB, we undertook a genome-wide association study in female Holstein–Friesian cattle with
592 cases and 559 age-matched controls from case herds. Cases and controls were categorised into distinct phenotypes: skin
test and lesion positive vs skin test negative on multiple occasions, respectively. These animals were genotyped with the
Illumina BovineHD 700K BeadChip. Genome-wide rapid association using linear and logistic mixed models and regression
(GRAMMAR), regional heritability mapping (RHM) and haplotype-sharing analysis identified two novel resistance loci that
attained chromosome-wise significance, protein tyrosine phosphatase receptor T (PTPRT; P¼4.8107) and myosin IIIB
(MYO3B; P¼5.4106). We estimated that 21% of the phenotypic variance in TB resistance could be explained by all of the
informative single-nucleotide polymorphisms, of which the region encompassing the PTPRT gene accounted for 6.2% of the
variance and a further 3.6% was associated with a putative copy number variant in MYO3B. The results from this study add to
our understanding of variation in host control of infection and suggest that genetic marker-based selection for resistance to bTB
has the potential to make a significant contribution to bTB control.
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INTRODUCTION
Bovine tuberculosis (bTB), caused by Mycobacterium bovis, is a
chronic respiratory disease characterised by granulomas in affected
tissues. This disease has substantial animal health and welfare
consequences, as well as a serious economic impact in the Great
Britain (GB), Northern Ireland (NI) and Republic of Ireland (ROI),
none of which have bTB-free status despite more than five decades of
compulsory skin testing and slaughter. The costs to governments in
these countries were d227 million (d152 million in GB, d23 million in
NI and d52 million in the ROI) in the 2010/2011 period alone
(Abernethy et al., 2013). In addition, bTB is increasing across the
European Union in both countries officially free of bTB (OTF) and in
non-OTF countries (Schiller et al., 2011) and remains a significant
risk in other OTF countries (Humblet et al., 2009). On a global scale,
this zoonotic pathogen is estimated to cause 10–15% of human TB
cases in the developing world (Michel et al., 2010) and is considered
to be the fourth most significant livestock disease in terms of impact
on human health and economics in developing countries, including
risks to other livestock and wildlife (Perry et al., 2002). Furthermore,
there is evidence that subclinical bTB has a negative impact on
productivity in dairy cows, increasing the costs incurred by the dairy
industry (Boland et al., 2010). As many parts of the world have no
active surveillance programmes and limited epidemiological studies,
the prevalence and impact of bTB worldwide is likely to be under-
estimated (Grace et al., 2012).
The risk of bTB to cattle is dependent on host, pathogen and
environmental factors and there is a broad spectrum of outcomes to
infection with M. bovis (Thoen et al., 2006), which are thought to be
similar to the effects of the related pathogen M. tuberculosis (Waters
et al., 2010) in humans. The wide range of responses is partly due to
the complexity of host–pathogen interactions across time involving
both the innate and adaptive immune systems. This complexity limits
efficacy of the current diagnostic tests (De la Rua-Domenech et al.,
2006), which in turn leads to difficulties in disease control. Control
measures in the United Kingdom and ROI involve statutory screening
of all cattle herds using the single intradermal comparative tuberculin
test (SICTT), followed by culling and movement restrictions when
skin test-positive cattle are detected. In addition, abattoir surveillance
is carried out by specialist meat inspectors on all SICCT test reactor
cattle looking for evidence of suspect tuberculous lesions in defined
organs and body sites. All cattle destined for the human food chain
are subjected to carcase inspection.
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Given the multifaceted issues surrounding bTB, it is likely that
control and eradication will require additional control strategies.
A potentially powerful approach would be the exploitation of genetic
variation in host resistance to bTB. The aim would be to selectively
breed cattle that are genetically more resistant to infection with
M. bovis, complementing other control approaches. Substantial
evidence suggests between-host genetic variation in resistance to TB
exists in many species, including humans, mice, deer and cattle
(reviewed by Allen et al., 2010). In particular, quantitative genetic
studies in herds in GB and ROI have shown convincingly that
significant heritability for host resistance exists in dairy cattle herds
(Bermingham et al., 2009, 2010; Brotherstone et al., 2010). Recently,
several studies have begun to address the identification of genetic loci
associated with bTB resistance. Polymorphisms in candidate genes,
SLC11A1 in African Zebu cattle (Kadarmideen et al., 2011) and
(TLR1) in Chinese Holsteins (Sun et al., 2012), have been significantly
associated with bTB outcome. Two genomic regions identified by the
microsatellite markers INRA111 and BMS2753 were also reported to
be associated with SICTT reactor status in UK cattle (Driscoll et al.,
2011). However, this study used a methodology via association tests
based on microsatellite markers in a mixed breed population, which
may not give robust results. Finally, a recent genome-wide association
study (GWAS) in Holsteins in ROI identified a genomic region on Bos
taurus chromosome 22 containing the taurine transporter gene
SLC6A6, which was suggestively associated with bTB resistance,
although it only explained a small proportion of the total variance
due to genetic factors (Finlay et al., 2012).
Thus, host genetic control of resistance to bTB in cattle is likely to
be complex and involve many loci of varying effect. Furthermore,
each study to date has had limitations in terms of the number of
animals studied and the genomic tools deployed. Therefore, to more
robustly explore the genetic basis of TB, we performed a GWAS in
naturally exposed Holstein–Friesian cattle from 146 dairy herds in
Northern NI, using both more animals and more powerful genomic
tools than previous studies. The aim was to demonstrate the existence
of genetic variation in the risk of bTB and to identify specific genomic
regions contributing to this variation.
MATERIALS AND METHODS
Phenotypes and case–control definitions
Our data were collected from commercial Holstein–Friesian cattle in NI.
Phenotypes used to define bTB status, and hence to group animals into cases
or controls, were derived from data collected as part of the NI bTB control
programme. Specifically, SICTT results and post-mortem abattoir inspection
data were made available from the Animal and Public Health Information
System (Abernethy et al., 2006) of the NI Department of Agriculture and Rural
Development.
The SICCT is the primary screening test in the bTB surveillance and control
programme in GB and Ireland (De la Rua-Domenech et al., 2006). M. bovis-
PPD antigen is injected into the neck of the animal and after 72h the size of
reaction to M. bovis-PPD is compared with the reaction similarly induced by
M. avium-PPD, to correct for potential exposure to other non-tuberculous
Mycobacterium spp. For our purposes, differences in reaction between M. bovis
and M. avium antigens of 44, 1–4 and o1mm were deemed positive,
inconclusive and negative, respectively. All cattle testing positive to the SICTT
are slaughtered and undergo standard meat inspection, including organ and
lymph node inspection and palpation. Lesions from SICTT-positive cattle
undergo histopathology and, from SICTT-positive cattle in which no lesions
are observed, M. bovis culture is performed on specified tissues. Confirmation
of M. bovis infection is determined through a combination of histopathology,
bacterial culture and genotyping (Skuce et al., 2010). The statutory bTB
control programme definition of an infected animal is based on the presence of
a positive SICTT and/or confirmed bacterial culture from diseased tissue.
Diagnostic sensitivity of all of these procedures is variable. For example, cattle
in the early stages of infection with positive SICTT diagnostic test results may
not disclose lesions at slaughter. Furthermore, cattle with advanced TB may be
anergic to the SICTT. Thus, as described by Allen et al. (2010), a spectrum of
phenotypes may be observed. To ensure that the cases in our study consisted of
truly infected animals, we defined the case phenotype as an animal that was
positive to both the SICTT and abattoir inspection, that is, animals that had
exhibited an immune response to M. bovis PPD as well as evidence of
pathology in the form of granuloma, lesions at slaughter, positive culture and
molecular confirmation ofM. bovis. Controls were defined as female cattle that
were raised contemporaneously with cases but had negative SICTT results
before sampling, and on every test (two or more occasions, mean¼ 10 tests)
after sampling, and had at least an equal opportunity of being exposed to the
pathogen as had their bTB case herd mates. Thus, as far as was feasible, we
minimised errors in phenotype assignment to improve the power of the study
to detect true associations.
Sampling cases and controls and definition of experimental
animals
Blood samples from 2975 tuberculin-positive cattle were sampled at slaughter
between August 2008 and June 2009. Of these animals, 822 had infection
confirmed through histopathology, bacterial culture and genotyping, and
hence were defined as potential cases.
To ensure accurate phenotype definition, and hence increase experimental
power, it is desirable for controls to have had a high probability of exposure
and both groups to come from epidemiologically comparable groups (Allen
et al., 2010). To achieve this, longitudinal epidemiological data for herds, from
which case cattle were sampled, were made available from the APHIS database.
The data comprised herd- and animal-level demographic data and animal
movement records, together with disease data: SICTT results, abattoir
inspection data, laboratory M. bovis culture and histopathology records. These
data were then used to define episodes of infection (Bermingham et al., 2009)
in case herds. We defined an episode as herd restrictions initiated by two
SICTT-positive cattle and terminated by two consecutive clear herd tests. In
total, 1355 cattle (685 cases, 670 controls) from 178 case herds were grouped
within defined episodes. Furthermore, cattle that were moved into the herd
during or within 6 weeks before the beginning of an episode were excluded, as
they may have been infected before entry to the herd. Age-matched control
animals were sampled from 165 episodes within 146 case herds, avoiding herd
episodes with two or fewer cases in an attempt to increase the probability of
exposure to infection. There were generally close to equal numbers of cases and
controls per farm, except for a bias for more controls from farms with a higher
prevalence to increase the probability of exposure to infection.
These longitudinal data were also used retrospectively to identify and
remove control cattle that subsequently exhibited a positive SICTT result as
well as negative animals that disclosed a lesion at slaughter. Male cattle were
also removed as they have transient residence in dairy production systems, and
hence likely to experience different M. bovis infection pressures. In total, 1223
female cattle (629 cases, 594 controls) from 146 case herds were selected for
DNA extraction and genotyping.
SNP chip genotyping
All DNA extraction and genotyping was conducted by the ARK-Genomics
laboratory at The Roslin Institute (http://www.ark-genomics.org). Genomic
DNA was extracted from blood samples using the Promega Maxwell 16 Blood
DNA Purification Kit (Promega, Madison, WI, USA) and DNA recovery from
each sample was quantified using Invitrogen’s Molecular Probes QuantitPico-
Green ds DNA Assay Kit (Invitrogen, Carlsbad, CA, USA) and measured on a
Thermo Labsystems Fluoroskan Ascent (Labotal Scientific Equipment, Abu-
Gosh, Israel). The extracted DNA samples were then normalised to 50ngml1.
Samples that failed to meet the 50ngml1 minimum DNA concentration
recommended for Illumina genotyping were removed.
The BovineHD Genotyping BeadChip (Illumina Inc., San Diego, CA, USA)
was then used to genotype the female cattle in the study, of which 628 cases
and 591 controls were genotyped. The BovineHD BeadChip assays 727 252
single-nucleotide polymorphism (SNP) markers with a median interval of 3 kb
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between SNPs (Illumina Inc.; 2011 BovineHD Genotyping BeadChip Data
Sheet: DNA Analysis. http://www.illumina.com/Documents/products/data-
sheets/datasheet_bovineHD.pdf). The BeadChips were scanned using iScan
(Illumina Inc.) and analysed using GenomeStudio software version 2011.1
(Illumina Inc.). The genotypes in this study were inferred based on forward
(positive) strand output from GenomeStudio. Stringent quality control
parameters were applied at the sample and SNP level to ensure reliability of
results. The minimal acceptable Gentrain call (GC) score for individual typings
was 0.60. Loci with a minor allelic frequency ofo5% or with call rateso90%
were excluded. Cattle with average GC scores below 0.65 or call rate ofo90%
were excluded. Finally, four pairs of samples that appeared to be duplicates
from the same animal, as indicated by their high concordance for SNP identity
by state, were removed. The final data set comprised 1151 animals (592 cases,
559 controls) genotyped at 617 010 loci. The SNP positions within a
chromosome were mapped to the bovine genome assembly (Bos taurus
UMD 3.0).
Statistical analyses
The genome-wide association analysis (GWA) was performed using the
genome-wide rapid association using mixed model and regression (GRAM-
MAR; Aulchenko et al., 2007) approach, this being a two-step approximation
to full mixed-model analyses. Pedigree information was not available for these
animals, so the pedigree relationship matrix was replaced with a marker-based
relationship matrix, that is, the identity-by-state matrix (G) adjusts for average
allele sharing or relatedness among sampled cattle and hence removed genetic
stratification. The identity-by-state coefficients between pairs of animals i and j
were estimated from genotype data as follows:
fij ¼ 1
n
Xn
k¼1
ðgik pkÞðgik pkÞ
pkð1 pkÞ
where gik is the genotype of the ith animal at the kth SNP (coded as 0, 1/2 and
1, for minor allele homozygote, heterozygote and common homozygote,
respectively), pk is the frequency of the major allele and n is the number of
SNPs used for kinship estimation in the statistical package GenABEL
(Aulchenko et al., 2007). The genomic relationship matrix was then calculated
as twice the kinship matrix.
Multidimensional scaling procedures were used to assess population
stratification in GenABEL. We performed a multidimensional scaling analysis
on the 1151 1151 matrix of genome-wide identity-by-state pairwise distances
(G), using the multidimensional scaling plot option in conjunction with
clustering. The first principal component values were plotted against the
second principal component values to identify potential clustering among the
cases and controls. However, no apparent clustering of cases and controls was
observed (Supplementary Figure 1) nor was there any observable difference
between animals classified as Holstein or Friesian (results not shown). We
concluded that there was no apparent substructure differentiating the case and
control samples; hence, fitting the genomic relationship matrix should be
sufficient to account for genetic structure in the population.
In the first step of the GRAMMAR approach, we fitted the following mixed
linear animal model to the data:
y ¼ mþXbþZaþ e ð1Þ
where y represents binary bTB status, m is the overall mean, b is the vector of
fixed effects, a is the additive genetic effect, matrices X and Z are incidence
matrices and e is a vector containing residuals, in the statistical package
ASReml (Gilmour et al., 2009). The covariance structure of the additive genetic
effects was accounted for by fitting the genomic relationship matrix G, as
described above. The binary trait was treated as a continuous trait as often
done in genetic and GWA studies (Bermingham et al., 2009; Minozzi et al.,
2012). Fixed effects were chosen to account for risks of bTB, these being breed
(Holstein vs Friesian), age at, season of, year of and reason for episode-
initiating SICTT. As well as providing residual values for step two, this model
also yields an estimated heritability for bTB resistance. The whole genomic
heritability (h2) was estimated from the variance components from Model (1)
using the formula s2a=ðs2a þs2e Þ (Nagamine et al., 2012), where s2a is the
additive genetic variance estimated using the G matrix and s2e is the residual
variance.
In the second step of the GRAMMAR approach, single SNP associations
were performed using the residuals from the mixed model as the phenotype;
these residuals capture much of the SNP effect and are independent of familial
structure. The residuals were regressed on each SNP in turn using GenABEL,
assuming an additive effect of the number of alleles on the trait. There was
little evidence of any general inflation of the test statistics (Supplementary
Figure 2). Nevertheless, the genome-wide degree of inflation (l) was calculated
to test and correct for any hidden substructure that may cause an inflation of
significant results. The l was less than one across all analyses, indicating that
genomic control for substructure (in which test statistics are scaled by 1/l) was
not required in subsequent analyses. Appropriate significance levels, after
correction for multiple testing, at the chromosome- and genome-wide level
were estimated using the permutation procedure (1151 permutations, as there
were 1151 animals) available in the GenABEL package. Associations were
deemed statistically significant at the 5% empirical significance cutoff.
An alternative means of identifying genomic regions associated with the
phenotype, known as RHM (Nagamine et al., 2012), was also investigated.
RHM is a variance components approach to map genomic regions influencing
complex traits, which combines information across SNPS. Each chromosome
is divided into windows of a predefined number of SNPs, and the additive
variance attributable to each window is estimated and compared with the null
hypothesis of no variance in that window (i.e., Model (1), above). The full
mixed model was as follows:
y ¼ mþXbþZaþZrþ e ð2Þ
where the notation and fitted effects are the same as Model (1), and r is
regional genomic additive genetic effect.
The whole genomic relationship matrix G was estimated using all SNPs and
the regional genomic additive effect was estimated from a regional genomic
relationship matrix constructed from adjacent SNPs from each region. In our
baseline analysis, window sizes of 100 or 50 SNPs were used to construct a
regional relationship matrix and the window was shifted every 50 or 25 SNPs,
respectively. In total, 11 767 and 22758 windows were tested across the 29
bovine autosomal chromosomes.
The regional heritability (h2r) was estimated from the variance components
from Model (2) using the formula: s2r =ðs2a þs2r þs2e Þ (Nagamine et al., 2012),
where s2r is the region-specific additive genetic variance. We used the
likelihood ratio test statistic (LRT)¼ 2ln(L0/L1) to test for the presence of
regional variance against the null hypothesis of no regional variance at each
window, where L0 and L1 represent the respective likelihood values under the
reduced (1) and full (2) models, respectively. Bonferroni correction was used to
adjust P-values for multiple testing at the chromosome and genome-wide level,
based on the number of windows tested. The LRTwas judged to be significant
at the 5% significance level.
To obtain unbiased estimates of the allele substitution and genotypic effects
of, and the variance (s2SNP) explained by SNPs found to be significant in the
GRAMMAR model, these SNPs were included in full mixed-model analyses
(Model (1)), separately and simultaneously as a covariate (i.e., regression on
allele number), as an additional fixed effect (i.e., three categories being the two
homozygous classes and heterozygous) or as a random effect (i.e., assuming
SNPBN [0, s2 SNP]), respectively. Further, a logistic animal linear mixed
model was fitted in ASReml to estimate the odds ratios of significant bTB-
associated risk alleles. These analyses were all conducted in ASReml.
Linkage disequilibrium (LD) blocks were inferred in regions of association
in Haploview using the Gabriel confidence interval method (Barrett et al.,
2005). The Gabriel protocol has an upper D0 confidence interval bound of
0.98, a lower D0 confidence interval bound of 0.70 and with 5% of informative
markers required to be in strong LD. Haplotypes, specified in terms of the
forward strand, were phased in PLINK (Purcell et al., 2007). The random effect
of phased haplotypes were fitted in Model (1) using the software ASReml.
Statistical significance of the fixed effect of genotype and haplotype was
determined using the F-test, with individual allele substitution effects evaluated
using a t-test. The LRT was performed to evaluate the random effects of
genotype/haplotypes on bTB status. All tests were judged significant at the
nominal 5% significance level.
To investigate experimental power, the non-centrality parameter (assuming
no phenotype misclassification, and perfect LD with the causal variant) (Yang
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et al., 2010) was calculated for SNPs contributing different levels of phenotypic
variance. The false-negative rate (b) was then calculated using non-central w2
distribution function in R package normal distribution, with threshold
corresponding to the genome-wide significance. Further, we then assumed
an expected r2¼ 0.5 between SNP and causative mutation. Power was then
calculated as 1b. Finally, for the most significant results found, we
investigated differential no-call rates within the case and control groups, or
across the genotypes using the PLINK missingness-by-phenotype and non-
random missingness routines, respectively (Purcell et al., 2007).
Identification of candidate genes
Genomic regions where significant results were obtained were further explored
to attempt to identify candidate genes underlying the loci. The location of
SNPs and gene annotations were based on the UMD_3.1 assembly (http://
www.ncbi.nlm.nih.gov/genome/82?project_id=33843). Transcripts and annota-
tion were downloaded on the UCSC Genome Browser (http://genome.ucs-
c.edu) and aligned with human, mouse, rat and zebra fish RefSeq mRNA
sequences using BLAT.
RESULTS
Overview of results
The heritability of bTB resistance in this study was estimated at 21.0%
(95% confidence interval: 8.6–33.4). Power analysis (under the
assumption of perfect case–control classification and perfect linkage
disequilibrium with the causal variant) has demonstrated that this
study is moderate (X0.80) to well-powered (X0.99) to detect
variants contributing X0.4% and 1.0% of phenotypic variance,
respectively, at the genome-wide level. The GWAS analysis identified
SNPs with significant association with resistance to bTB on chromo-
somes 2 and 13. A notable deviation of the observed significance level
from that expected by chance was observed, suggestive of the presence
of true associations (Supplementary Figure 2). The Manhattan plot of
observed P-values (Figure 1) revealed a set of seven closely located
SNPs (rs42494357, rs110465273, rs42494342, rs109809949,
rs109042660, rs137562332, rs132841890; Table 1 and Figure 2)
between 71.78 and 71.79Mb on chromosome 13 and a single SNP
(rs136617760; Table 1 and Supplementary Figure 3) at 25.90Mb on
chromosome 2, which were statistically significant at the chromo-
some-wide level (empirical P-value from permutation testingo0.05).
When fitted in a full mixed model, the SNP (rs136617760) on
chromosome 2 explained 4.0% (w2¼ 12.86; P-value 3.4 1004), and
the GG haplotype on chromosome 13 (see below) explained 6.6%
(w2¼ 21.21; P-value 4.3 1006) of phenotypic variance. When fitted
simultaneously, we estimated that 18.8% of the variance in TB
resistance can be explained by polygenic effects other than the two
significant regions, 6.2% can be explained by the GG haplotype on
chromosome 13 and a further 3.6% by rs136617760 on chromosome
2 (w2¼ 33.46; P-value 7.3 1009).
Chromosome 13 associations
The seven SNPs in the region of association on chromosome 13 had
high call rates approaching 100% (Table 2) and were in Hardy–
Weinberg equilibrium (HWE) (P40.05; Table 2). The SNPs were also
in strong LD (Figure 3a), and close together (o10 kb apart; Table 2),
thus making it currently impossible to distinguish them in terms of
their effect on the infection phenotype (Table 1). The major allele A of
the top hit rs110465273 was the allele associated with greater risk in
this population (F-test 29.09; P-value 6.1 107), with an additive
model providing the best fit (Table 1). Two haplotype blocks were
found in the region of association on chromosome 13 (Figure 3a).
The first haplotype block 1 containing 15 SNPs—rs109910368 to
rs137562332 (Figure 3a)—was significantly associated with resistance
to bTB (F-test 23.28; P-value 1.6 106). Three frequent haplotypes
(50-GCAGAGGAAGAGAGG-30, 50-ACAGAGGAAGAGAGG-30 and
50-AAGAGAAGGAGAGAA-30; haplotypes 1, 2 and 3, respectively)
were predicted with frequencies of 0.42, 0.32 and 0.21, respectively.
The additive model provided the best fit for haplotype 3.
Cattle carrying two copies of this haplotype had lower risk of bTB
infection than those carrying one (Table 3). The second haplotype
block 2 containing two SNPs—rs132841890 and rs134752210
(Figure 3a)—was also significantly associated with resistance to bTB
(F-test 25.63; P-value 4.8 107). Three frequent haplotypes (AA,
AG and GG) were predicted with frequencies of 0.42, 0.35 and 0.23,
respectively. The additive model also provided the better fit for the
GG haplotype. Cattle carrying two copies of this haplotype had lower
risk than those carrying one (Table 3). The phased data of two
haplotypes was highly confounded; the effect of haplotype 3 (F-test
0.04; P-value 8.4 101) was reduced to near zero when it was fitted
simultaneously with the GG haplotype (F-test 25.61; P-value
4.9 107). The phased GG haplotype data was also confounded
with the top hit rs110465273 and reduced the allele substitution effect
to near zero (F-test 0.01; P-value 9.2 101) when fitted together in a
single analysis.
The SNP rs132841890 in the GG haplotype block is close to the 30
end of intron 7 of the gene for bovine PTPRT, a gene that is highly
conserved between eutherian mammalian species and is in a region of
high synteny (Figure 2). The other six significant SNPs are in the 30
end of haplotype block 1 and are close to the beginning of intron 8 of
this gene (Figures 2 and 3a).
Chromosome 2 associations
The SNP (rs136617760) on chromosome 2 had a moderate call rate of
92% (Table 2). On examination, the SNP displayed no differential
missing rates between cases and controls (P40.05) nor non-random
genotyping failure (P40.05). However, the SNP was not in HWE in
either the cases or controls (Po0.0001; Table 2) and had low LD with
adjacent SNPs (D0o0.50; Figure 3b). The major C allele for
rs136617760 was associated with the greater risk of bTB in this
population, with the dominance model providing the best fit
(Table 1). The SNP falls within intron 32 of the gene for bovine
myosin IIIB (MYO3B) (Supplementary Figure 3), a gene that is highly
conserved across species and is found within a region of high synteny.
Further inspection of the cluster plot for rs136617760 revealed that in
addition to the 93 samples that were not called, there was an excess of
B alleles (alternative base forms at a specific genomic position), as well
as a number of multimodal clusters (Supplementary Figure 4). The
two SNPs flanking rs136617760 (rs134930642 and rs43293650) are
Figure 1 Manhattan plots showing P-values of association for each SNP,
expressed as log 10 (P-value). Manhattan plot showing P-values from the
GRAMMAR approach. The y axis shows the –log10 P-values of 617010
SNPs, and the x axis shows the chromosomal positions.
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also within the same intron 32 of MYO3B (Supplementary Figure 3),
yet they are in the adjacent haplotype blocks (Figure 3b); neither of
them showed any association with bTB (results not shown). The
cluster plots of these flanking SNPs displayed normal genotype
clusters (data not shown).
Regional heritability mapping
The RHM approach did not uncover new regions that explain
additional trait variation beyond those identified from GWAS.
However, this approach also identified the region of association on
chromosome 13 (Figure 2), which was significant at the chromosome-
wide level (w2¼ 18.05; P-value 1.0 1004). The estimated herit-
ability for bTB in this region was 2.5%. The region of association on
chromosome 2 (Supplementary Figure 3) was not identified by RHM.
The size of the SNP window size did not greatly influence the
performance of RHM in this study.
To further explore the association within MYO3B and PTPRT, we
estimated the phenotypic variance explained by the two genes
using regional gene-wise kinship matrices. No significant additive
variance was detected using the 134 SNPs within MYO3B present
on the SNP chip (LRT 0.11; P-value 7.5 101), indicating that the
associated phenotypic variance is generated by a single SNP
(Supplementary Figure 3). However, 303 SNPs in the PRPRT gene
explained 1.5% (LRT 7.23; P-value 7.2 1003). Nevertheless,
when any single SNP within the region of association was fitted
simultaneously as a random covariate in the analysis, the regional
heritability estimate was reduced to 0.0%. The GG haplotype
explained 6.6% of phenotypic variance (LRT 21.12; P-value
4.3 1006). This indicated that the phenotypic variance within
PTPRT is generated by the region of association identified by
GWAS (Figure 2).
DISCUSSION
A GWAS, regional heritability and haplotype-sharing analyses have
identified two potential novel loci containing candidate genes for
resistance to bTB in cattle. In addition, a substantial proportion of
variation in resistance to bTB (21%) is determined by a sum of all the
SNP genotypes, indicating that the trait is polygenic. Further support
for a genomic basis to host resistance to bTB in Holstein–Friesian
dairy cattle has recently been reported from the ROI (Finlay et al.,
2012). In cattle populations, there is a high level of relatedness,
particularly Holstein–Friesian dairy cattle where the effective popula-
tion size is very small, which may inflate the rate of false-positive
associations between the trait and the markers (Minozzi et al., 2012).
In this study however, we used a polygenic model that included the
genomic relationship matrix that should have removed any statistical
anomalies arising because of population structure. In principle,
population admixture could reduce the experimental power. However,
multidimensional scaling did not reveal any apparent differential
clustering of Holstein and Friesian cows. Under the assumption that
we have a population of cows from the same breed, and no phenotype
misclassification our power analysis demonstrated that this study is
sufficiently powered to detect genome-wide significant variants that
contribute moderate to high levels of phenotypic variance. Never-
theless, the previously reported association with resistance to bTB in
the locus containing the taurine transporter gene SLC6A6 (Finlay
et al., 2012) was not replicated in our study. Although there is a
possibility that the significant results of either study may include false
positives, there can be many reasons why significant associations do
not replicate across populations. For example, even if the same
quantitative trait loci is segregating in both populations, different
allele frequencies of either the marker or causative mutation, or
different linkage phases between marker and quantitative trait loci,
can lead to different results.
The case–control study design typically entails the identification of
cases (affected individuals) and controls (i.e., unaffected individuals)
that match the cases with regard to environment and genetic
background (Allen et al., 2010). Thus, to estimate the influence of
the host genotype on the outcome of bTB infection, the cases and
controls in this study were assigned using stringent criteria. As
described in humans, a spectrum of phenotypes is observed following
exposure to M. bovis, ranging from no apparent infection to
asymptomatic carriage (cattle with positive SICTT, but no evidence
of pathology or M. bovis culture) through to progressive disease
(cattle with a positive skin test that also exhibit evidence of pathology
and M. bovis culture) (Allen et al., 2010). This is partly due to the
Table 1 Results from the additive and genotype models of significantly associated variants in the GWAS
SNP Additive model Genotype model
P-valuea Allele substitution effect P-value
a
Heterozygous non-ref. effect Homozygous non-ref. effect
b(95% CI)
b OR(95% CI)
c b(95% CI)
b OR(95% CI)
c b(95% CI)
b OR(95% CI)
c
Rs136617760 6.81006 0.10(0.15, 0.05) 0.64(0.51–0.81) 4.51005 0.20(0.35, 0.05) 0.41(0.20–0.86) 0.19(0.30, 0.09) 0.36(0.21–0.62)
Rs42494357 8.61007 0.13(0.18, 0.08) 0.58(0.46–0.73) 1.51005 0.13(020, 0.07) 0.57(0.43–0.75) 0.26(0.39, 0.12) 0.35(0.19–0.65)
Rs110465273 6.11007 0.13(0.18, 0.08) 0.58(0.46–0.73) 1.51005 0.13(020, 0.07) 0.57(0.43–0.75) 0.26(0.39, 0.12) 0.36(0.19–0.69)
Rs42494342 5.91007 0.13(0.18, 0.08) 0.58(0.46–0.73) 1.51005 0.13(020, 0.07) 0.52(0.39–0.71) 0.26(0.39, 0.12) 0.35(0.19–0.65)
Rs109809949 1.21006 0.13(0.18, 0.08) 0.58(0.46–0.73) 2.81005 0.13(0.19, 0.07) 0.53(0.39–0.71) 0.25(0.39, 0.12) 0.37(0.19–0.71)
Rs109042660 5.21007 0.13(0.18, 0.08) 0.58(0.46–0.73) 1.31005 0.13(0.20, 0.07) 0.52(0.38–0.70) 0.26(0.39, 0.12) 0.37(0.19–0.71)
Rs137562332 6.11007 0.13(0.18, 0.08) 0.58(0.46–0.73) 1.51005 0.13(020, 0.07) 0.57(0.43–0.75) 0.26(0.39, 0.12) 0.35(0.19–0.65)
Rs132841890 5.91007 0.13(0.18, 0.08) 0.58(0.46–0.73) 1.41005 0.13(0.19, 0.06) 0.58(0.44–0.77) 0.27(040, 0.13) 0.33(0.18–0.61)
Abbreviations: CI, confidence interval; gBLUP, genomic best linear unbiased prediction; GWAS, genome-wide association study; non-ref., non-reference (minor) allele on Illumina BovineHD
BeadChip; OR, odds ratio; P-value, probability of obtaining the observed effect size (b), assuming that the null hypothesis is true; SNP, single-nucleotide polymorphism GenBank accession
number.
aP-values from genome-wide rapid association using linear and logistic mixed models and regression in GenABEL.
bEffect size estimated from gBLUP using a normal link function.
cOR estimated from gBLUP using a logit link function.
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time lag between exposure and emergence of clinical signs, and the
immunological anergy that develops in late-stage bTB infection (De la
Rua-Domenech et al., 2006), but the range of phenotypes is also a
result of host, pathogen and environmental factors, including limita-
tions of the tests. However, our requirement for cases to be positive
both to the SICTT, abattoir inspection and molecular confirmation of
M. bovis infection removed ambiguity over the case definition,
particularly as the SICTT and abattoir tests are known to have high
specificity (499%; De la Rua-Domenech et al., 2006). Nevertheless, it
is important to note that in an attempt to maximise the power in this
study, we have excluded many potentially interesting phenotypes from
the case spectrum. In particular, cattle that become infected (SICTT
Human PTPRT
Bovine PTPRT
Chr 13         71, 500, 000        71, 600, 000        71, 700, 000       71, 800, 000       71, 900, 000         72, 000, 000        72, 100, 000        72, 200, 000       72, 300, 000 
Bov EST AW657395
Bov EST BI542264.1
SNPs
Bov cDNA EH163068 snRNA U6 Bov EST CX952742.1
500 kb Bos tau 6
a
b
Figure 2 Regional association plot of chromosome 13 (a) and UCSC browser image (b) of the region surrounding significant SNPs on BTA 13 (UMD_3.1,
Btau 6.1). The y axis shows the –log10 P-values from GWA and the estimated regional heritabilities (RH) and corresponding values for the LRT of the
regional heritability from the RHM approaches for tuberculosis resistance, and transcribed genes (TG) on chromosome 13. The x axis shows the
chromosomal positions. The shaded area highlights the region of association in PTPRT. The label SNPs refers to rs132841890, rs42494357,
rs110465273, rs42494342, rs109809949, rs134449285 and rs137562332; the SNPs are shown in relation to the following sequences: bovine PTPRT
predicted transcript XM_002692322.1 (bovine PTPR); RefSeq (NM_133170.3) mRNA transcript 1 (human PTPRT); three bovine EST sequences, one
bovine cDNA clone and a bovine U6 spliceosomal RNA (snRNA U6) also map to this region as shown.
Table 2 Summary of genotype data from significantly associated variants in the GWAS
SNP Chr. Position (bp) N Ref./non-ref. MAF MAFca MAFco HWE HWEca HWEco
Rs136617760 2 25899036 1058 C/A 0.11 0.07 0.15 7.51093 2.21039 2.01052
Rs42494357 13 71782488 1151 G/A 0.22 0.18 0.27 9.01001 8.21001 4.21001
Rs110465273 13 71783216 1151 A/G 0.22 0.18 0.27 9.01001 8.21001 4.21001
Rs42494342 13 71784332 1147 G/A 0.22 0.18 0.27 9.71001 7.81001 4.61001
Rs109809949 13 71787722 1148 A/G 0.22 0.18 0.26 10.01001 8.01001 5.21001
Rs109042660 13 71788784 1150 G/A 0.22 0.18 0.27 9.01001 8.21001 4.11001
Rs137562332 13 71789620 1151 G/A 0.22 0.18 0.27 9.01001 8.21001 4.21001
Rs132841890 13 71791844 1151 A/G 0.23 0.18 0.27 9.31001 9.81001 5.51001
Abbreviations: bp, base pairs; ca, cases; Chr., chromosome; co, controls; GWAS, genome-wide association study; HWE, probability that the SNP is in Hardy–Weinberg equilibrium; MAF, minor
allele frequency; N, number of genotyped samples; non-ref., non-reference (minor) allele on BeadChip; Position, Illumina BovineHD BeadChip SNP map position on the chromosome; Ref.,
reference (major) allele on BeadChip; SNP, single-nucleotide polymorphism GenBank accession number.
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positive) but never go on to develop disease-associated pathology
(abattoir negative), or infected cattle that rapidly develop progressive
disease (i.e., potentially abattoir positive) and become anergic to the
SICTT, may become a latent source of infection in the herd. An
investigation of their genotypes could reveal further insights into
associations with bTB.
Control definition is more challenging. The imperfect test sensi-
tivity of the SICTT diagnostic tool used in this study results in the
non-detection of around 10% of infected cattle (Clegg et al., 2010).
The second diagnostic tool, post-mortem inspection is even less
sensitive, with only around 47% of M. bovis infected cattle detected
(Corner et al., 1990). These relatively low sensitivities mean that
classifying the control samples as exposed to M. bovis yet not infected
is inherently more difficult. Therefore, to increase the probability that
the controls represented resistant animals, all controls were sampled
from bTB-restricted case herds favouring higher prevalence herds in
an attempt to increase their probability of exposure to infection
(Bishop et al., 2012). Furthermore, individual cattle were only
included if they also had two or more consecutive negative SICTT
diagnoses. In addition, where feasible, prospective SICTT and abattoir
inspection results were used to remove control cattle that were
subsequently diagnosed as bTB positive. Although it is still possible
that some of the SICTT-negative cattle were, or subsequently became,
infected (i.e., should have been reclassified as cases), this would only
have the effect of reducing the power of our study and would not lead
to false-positive associations. In fact, in many case–control designs
used in humans, controls are simply a random sample of individuals
(Craddock et al., 2010). It must be stated, however, that the control
definition that would have maximised power in this study is SICTT-
and abattoir-negative cattle. It was not logistically feasible in the given
time frame of this study, but as more data become available it may be
possible to assign prospectively abattoir results to controls and
perform analysis on such a data set.
This study identified seven additive SNPs in high LD on BTA 13
that were significantly associated with resistance to bTB. Haplotype-
sharing analysis showed strong support for two SNP block of LD
from 71791 844 to71 793 206 bp at the 30 end of the seventh intron in
PTPRT. PTPRT belongs to the type IIB PTPm-like subfamily of
receptor protein tyrosine phosphatases, which are essential for the
regulation of signalling pathways in which they dephosphorylate
tyrosine residues on a variety of targets. So far, no variants of PTPRT
have been associated with infectious disease susceptibility. However,
PTPRTmutations are commonly associated with cancer (Wang et al.,
2004) and SNP variants with type 2 diabetes (Hayes et al., 2007),
systemic lupus erythematosus (Armstrong et al., 2009) and rheuma-
toid arthritis (Harley et al., 2008). The functional importance of many
Figure 3 LD maps of the candidate regions. Pairwise SNP LD maps of
(a) chromosomes 13 and (b) 2 containing the most significantly associated
variants identified in our GWAS using the GRAMMAR approach (SNP
accession identifiers underlined). LD is based on D0 (coefficient of LD), and
maps are drawn based on the genotype data of all case and control
samples. The D 0 values are shown inside each diamond. Red diamonds
without a number represent D 0 ¼1. The black triangles indicate the LD
blocks identified by Haploview using Gabriel’s method (Gabriel et al.,
2002).
Table 3 Results from the additive and haplotype models of two haplotype blocks in the region of association on chromosome 13
Haplotype block
Additive model Haplotype model
P-valuea Haplotype substitution effect P-value
a
Heterozygous non-ref. effect Homozygous non-ref. effect
b(95% CI)
b OR(95% CI)
c b(95% CI)
b OR(95% CI)
c b(95% CI)
b OR(95% CI)
c
1 1.61006 0.13(0.18, 0.08) 0.58(0.46, 0.73) 9.61006 0.12(0.19, 0.06) 0.59(0.45, 0.78) 0.27(0.41, 0.13) 0.32(0.17, 0.63)
2 4.81007 0.13(0.18, 0.08) 0.58(0.46, 0.72) 3.11006 0.12(0.19, 0.07) 0.58(0.44, 0.76) 0.27(0.41, 0.14) 0.33(0.18, 0.61)
Abbreviations: CI, confidence interval; gBLUP, genomic best linear unbiased prediction; non-ref., non-reference (minor) haplotype on Illumina BovineHD BeadChip; OR, odds ratio; P-value,
probability of obtaining the observed effect size (b), assuming that the null hypothesis is true.
aP-values from genome-wide rapid association using linear and logistic mixed models and regression in GenABEL.
bEffect size estimated from gBLUP using a normal link function.
cOR estimated from gBLUP using a logit link function.
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receptor protein tyrosine phosphatases is still being unravelled
(Tonks, 2006).
A single dominant SNP on BTA 2 was also significantly associated
with resistance to bTB. However, it is possible that this singleton
association may represent a false association owing to genotyping
artefacts or chance. Indeed, the region was not confirmed by either
RHM or haplotype-sharing analysis. However, our results may be
explicable by the genotype pattern results for this SNP; multimodal
genotype clusters for this SNP were observed both in the present
study as well as an independent Australian Holstein–Friesian cattle
population (Dr Ben Hayes, personal communication; Supplementary
Figure 5). Such features can be characteristic of a copy number
variant (McCarthy et al., 2008). Further investigation would be
required to confirm the hypothesis that this locus represents a copy
number variant.
In any case, the putative regions of association on BTA 13 and
BTA 2 may be due to single quantitative trait loci in LD with the
regions of the SNPs, or they may indicate the presence of more than
one quantitative trait loci in these regions. The possibility that these
associations are due to chance should also be considered, and thus
functional validation and replication of these findings in independent
populations is critical.
The results of this study are consistent with a polygenic model,
with 18.8% of variation in resistance to bTB captured by SNPs other
than those associated with PTPRT and MYO3B, and 6.2% and 3.6%
by the regions of associations in the PTPRT and MYO3B genes,
respectively. The polygenic component reported in this study is
almost identical to the heritability estimates of 18% reported for
resistance to bTB in two recent quantitative genetic studies in Irish
and British Holstein–Friesian cow populations (Bermingham et al.,
2009; Brotherstone et al., 2010). These results indicate that genetic
improvement in bTB resistance is possible, most likely through
genomic selection methods originally suggested by Meuwissen et al.
(2001), rather than relying on individual SNPs, whose frequency in
the population as a whole is still unknown. In principle, this is
possible as the dairy industry in the United Kingdom has imple-
mented genomic selection for many traits. However, further research
is required to determine optimal selection methods for resistance to
bTB that are feasible in practice. Genetic and phenotypic correlations
of this trait with other economically important traits also need to be
quantified so that bTB resistance can be weighted appropriately
within the Holstein–Friesian dairy cattle breeding objectives.
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